191 related articles for article (PubMed ID: 30705062)
1. Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.
Toresson Grip E; Svensson AM; Miftaraj M; Eliasson B; Franzén S; Gudbjörnsdottir S; Steen Carlsson K
Diabetes Care; 2019 Apr; 42(4):545-552. PubMed ID: 30705062
[TBL] [Abstract][Full Text] [Related]
2. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
[TBL] [Abstract][Full Text] [Related]
3. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.
St Charles ME; Sadri H; Minshall ME; Tunis SL
Clin Ther; 2009 Mar; 31(3):657-67. PubMed ID: 19393856
[TBL] [Abstract][Full Text] [Related]
4. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
[TBL] [Abstract][Full Text] [Related]
5. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.
Roze S; Valentine WJ; Zakrzewska KE; Palmer AJ
Diabet Med; 2005 Sep; 22(9):1239-45. PubMed ID: 16108855
[TBL] [Abstract][Full Text] [Related]
6. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
7. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
[TBL] [Abstract][Full Text] [Related]
8. Canadian Real-World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry.
Brown RE; Vienneau T; Aronson R
Diabet Med; 2021 Jun; 38(6):e14420. PubMed ID: 33040383
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.
St Charles M; Lynch P; Graham C; Minshall ME
Value Health; 2009; 12(5):674-86. PubMed ID: 19171006
[TBL] [Abstract][Full Text] [Related]
11. Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.
Thorius IH; Husemoen LLN; Nordsborg RB; Alibegovic AC; Gall MA; Petersen J; Mathiesen ER
Diabetologia; 2023 May; 66(5):826-836. PubMed ID: 36640191
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States.
Kamble S; Schulman KA; Reed SD
Value Health; 2012; 15(5):632-8. PubMed ID: 22867771
[TBL] [Abstract][Full Text] [Related]
13. Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control.
Jendle JH; Rawshani A; Svensson AM; Avdic T; Gudbjörnsdóttir S
J Diabetes Sci Technol; 2016 Sep; 10(5):1027-33. PubMed ID: 27226388
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
15. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.
Steineck I; Cederholm J; Eliasson B; Rawshani A; Eeg-Olofsson K; Svensson AM; Zethelius B; Avdic T; Landin-Olsson M; Jendle J; Gudbjörnsdóttir S;
BMJ; 2015 Jun; 350():h3234. PubMed ID: 26100640
[TBL] [Abstract][Full Text] [Related]
16. Switching from multiple daily injections to CSII pump therapy: insulin expenditures in type 2 diabetes.
David G; Gill M; Gunnarsson C; Shafiroff J; Edelman S
Am J Manag Care; 2014 Nov; 20(11):e490-7. PubMed ID: 25730348
[TBL] [Abstract][Full Text] [Related]
17. Resource utilization with insulin pump therapy for type 2 diabetes mellitus.
Lynch PM; Riedel AA; Samant N; Fan Y; Peoples T; Levinson J; Lee SW
Am J Manag Care; 2010; 16(12):892-6. PubMed ID: 21348559
[TBL] [Abstract][Full Text] [Related]
18. Real-world outcomes of insulin pump compared to injection therapy in a population-based sample of children with type 1 diabetes.
Burckhardt MA; Smith GJ; Cooper MN; Jones TW; Davis EA
Pediatr Diabetes; 2018 Dec; 19(8):1459-1466. PubMed ID: 30129154
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness analysis on continuous subcutaneous insulin infusion and multi-point daily insulin injections in the treatment program of type 2 diabetes].
Shu J; Zeng LY; Mu PW; Wang MM; Zhang GC; Chen YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jul; 30(7):737-9. PubMed ID: 19957604
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic benefits of integrated pump/CGM technology therapy in patients with type 1 diabetes in Colombia.
Gomez AM; Alfonso-Cristancho R; Orozco JJ; Lynch PM; Prieto D; Saunders R; Roze S; Valencia JE
Endocrinol Nutr; 2016 Nov; 63(9):466-474. PubMed ID: 27595241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
